nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—psoriasis—skin cancer	0.666	1	CtDrD
Clobetasol propionate—CYP1A2—Imiquimod—skin cancer	0.075	0.317	CbGbCtD
Clobetasol propionate—CYP1A1—Dacarbazine—skin cancer	0.0705	0.298	CbGbCtD
Clobetasol propionate—CYP1A2—Vemurafenib—skin cancer	0.0411	0.174	CbGbCtD
Clobetasol propionate—CYP1A2—Dacarbazine—skin cancer	0.0315	0.133	CbGbCtD
Clobetasol propionate—CYP1A2—Fluorouracil—skin cancer	0.0185	0.0781	CbGbCtD
Clobetasol propionate—Application site dryness—Imiquimod—skin cancer	0.00716	0.0757	CcSEcCtD
Clobetasol propionate—Pustule—Imiquimod—skin cancer	0.0061	0.0645	CcSEcCtD
Clobetasol propionate—Psoriasis flare-up—Imiquimod—skin cancer	0.00452	0.0478	CcSEcCtD
Clobetasol propionate—Application site burn—Imiquimod—skin cancer	0.00394	0.0416	CcSEcCtD
Clobetasol propionate—Application site pruritus—Imiquimod—skin cancer	0.00338	0.0357	CcSEcCtD
Clobetasol propionate—Hyperadrenocorticism—Temozolomide—skin cancer	0.0032	0.0338	CcSEcCtD
Clobetasol propionate—Application site irritation—Imiquimod—skin cancer	0.00297	0.0314	CcSEcCtD
Clobetasol propionate—Instillation site pain—Imiquimod—skin cancer	0.00253	0.0268	CcSEcCtD
Clobetasol propionate—Application site burn—Fluorouracil—skin cancer	0.00217	0.023	CcSEcCtD
Clobetasol propionate—Leukoderma—Imiquimod—skin cancer	0.00194	0.0205	CcSEcCtD
Clobetasol propionate—Telangiectasia—Fluorouracil—skin cancer	0.00193	0.0204	CcSEcCtD
Clobetasol propionate—Application site pain—Imiquimod—skin cancer	0.00188	0.0198	CcSEcCtD
Clobetasol propionate—Skin striae—Bleomycin—skin cancer	0.00184	0.0195	CcSEcCtD
Clobetasol propionate—Application site reaction—Imiquimod—skin cancer	0.00176	0.0186	CcSEcCtD
Clobetasol propionate—Skin hypertrophy—Bleomycin—skin cancer	0.00154	0.0163	CcSEcCtD
Clobetasol propionate—Folliculitis—Vemurafenib—skin cancer	0.00154	0.0163	CcSEcCtD
Clobetasol propionate—Fluocinonide—SMO—skin cancer	0.00153	0.837	CrCbGaD
Clobetasol propionate—Skin hyperpigmentation—Imiquimod—skin cancer	0.00139	0.0147	CcSEcCtD
Clobetasol propionate—Folliculitis—Imiquimod—skin cancer	0.00131	0.0139	CcSEcCtD
Clobetasol propionate—Psoriasis—Imiquimod—skin cancer	0.00131	0.0139	CcSEcCtD
Clobetasol propionate—Allergic contact dermatitis—Fluorouracil—skin cancer	0.0013	0.0138	CcSEcCtD
Clobetasol propionate—Pain in extremity—Vismodegib—skin cancer	0.00114	0.012	CcSEcCtD
Clobetasol propionate—Application site pain—Fluorouracil—skin cancer	0.00104	0.011	CcSEcCtD
Clobetasol propionate—Rash pustular—Imiquimod—skin cancer	0.00103	0.0109	CcSEcCtD
Clobetasol propionate—Tingling sensation—Imiquimod—skin cancer	0.00103	0.0109	CcSEcCtD
Clobetasol propionate—Stinging—Imiquimod—skin cancer	0.00102	0.0108	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Bleomycin—skin cancer	0.000985	0.0104	CcSEcCtD
Clobetasol propionate—Application site reaction—Fluorouracil—skin cancer	0.000971	0.0103	CcSEcCtD
Clobetasol propionate—Tenderness—Imiquimod—skin cancer	0.000946	0.01	CcSEcCtD
Clobetasol propionate—Eruption—Dactinomycin—skin cancer	0.000889	0.0094	CcSEcCtD
Clobetasol propionate—Folliculitis—Dactinomycin—skin cancer	0.00087	0.0092	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Vismodegib—skin cancer	0.000773	0.00817	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Fluorouracil—skin cancer	0.000766	0.0081	CcSEcCtD
Clobetasol propionate—Pain in extremity—Vemurafenib—skin cancer	0.000702	0.00743	CcSEcCtD
Clobetasol propionate—Alopecia—Vismodegib—skin cancer	0.000695	0.00735	CcSEcCtD
Clobetasol propionate—Tenderness—Bleomycin—skin cancer	0.000672	0.0071	CcSEcCtD
Clobetasol propionate—Dry skin—Vemurafenib—skin cancer	0.000644	0.00681	CcSEcCtD
Clobetasol propionate—Purpura—Imiquimod—skin cancer	0.000621	0.00657	CcSEcCtD
Clobetasol propionate—Pain in extremity—Imiquimod—skin cancer	0.000599	0.00633	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.000579	0.00612	CcSEcCtD
Clobetasol propionate—Tingling sensation—Fluorouracil—skin cancer	0.000567	0.00599	CcSEcCtD
Clobetasol propionate—Stinging—Fluorouracil—skin cancer	0.000562	0.00595	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Docetaxel—skin cancer	0.000553	0.00585	CcSEcCtD
Clobetasol propionate—Skin disorder—Vismodegib—skin cancer	0.000543	0.00574	CcSEcCtD
Clobetasol propionate—Eruption—Docetaxel—skin cancer	0.000534	0.00565	CcSEcCtD
Clobetasol propionate—Eye irritation—Fluorouracil—skin cancer	0.000533	0.00564	CcSEcCtD
Clobetasol propionate—Tenderness—Fluorouracil—skin cancer	0.000522	0.00552	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Vemurafenib—skin cancer	0.000479	0.00506	CcSEcCtD
Clobetasol propionate—Pain—Vismodegib—skin cancer	0.000478	0.00505	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Vemurafenib—skin cancer	0.000477	0.00505	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Fluorouracil—skin cancer	0.00045	0.00476	CcSEcCtD
Clobetasol propionate—Alopecia—Vemurafenib—skin cancer	0.000429	0.00454	CcSEcCtD
Clobetasol propionate—Erythema—Vemurafenib—skin cancer	0.000423	0.00447	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Imiquimod—skin cancer	0.000407	0.00431	CcSEcCtD
Clobetasol propionate—Vascular purpura—Temozolomide—skin cancer	0.000401	0.00424	CcSEcCtD
Clobetasol propionate—Pruritus—Vismodegib—skin cancer	0.000395	0.00418	CcSEcCtD
Clobetasol propionate—Eye irritation—Docetaxel—skin cancer	0.000385	0.00407	CcSEcCtD
Clobetasol propionate—Purpura—Temozolomide—skin cancer	0.000372	0.00394	CcSEcCtD
Clobetasol propionate—Alopecia—Imiquimod—skin cancer	0.000366	0.00387	CcSEcCtD
Clobetasol propionate—Erythema—Imiquimod—skin cancer	0.000361	0.00381	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000358	0.00378	CcSEcCtD
Clobetasol propionate—Rash—Vismodegib—skin cancer	0.000352	0.00372	CcSEcCtD
Clobetasol propionate—Dermatitis—Vismodegib—skin cancer	0.000352	0.00372	CcSEcCtD
Clobetasol propionate—Infection—Vemurafenib—skin cancer	0.000343	0.00363	CcSEcCtD
Clobetasol propionate—Skin disorder—Vemurafenib—skin cancer	0.000335	0.00355	CcSEcCtD
Clobetasol propionate—Dry skin—Temozolomide—skin cancer	0.000329	0.00348	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000305	0.00322	CcSEcCtD
Clobetasol propionate—Dry skin—Fluorouracil—skin cancer	0.000303	0.00321	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Bleomycin—skin cancer	0.000293	0.0031	CcSEcCtD
Clobetasol propionate—Infection—Imiquimod—skin cancer	0.000292	0.00309	CcSEcCtD
Clobetasol propionate—Skin disorder—Imiquimod—skin cancer	0.000286	0.00302	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Temozolomide—skin cancer	0.00028	0.00296	CcSEcCtD
Clobetasol propionate—Paraesthesia—Imiquimod—skin cancer	0.000264	0.00279	CcSEcCtD
Clobetasol propionate—Alopecia—Bleomycin—skin cancer	0.00026	0.00275	CcSEcCtD
Clobetasol propionate—Erythema—Bleomycin—skin cancer	0.000256	0.00271	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Vemurafenib—skin cancer	0.000254	0.00269	CcSEcCtD
Clobetasol propionate—Pain—Imiquimod—skin cancer	0.000252	0.00266	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Temozolomide—skin cancer	0.000247	0.00261	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Temozolomide—skin cancer	0.000245	0.00259	CcSEcCtD
Clobetasol propionate—Pruritus—Vemurafenib—skin cancer	0.000244	0.00258	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Temozolomide—skin cancer	0.000244	0.00258	CcSEcCtD
Clobetasol propionate—Alopecia—Dactinomycin—skin cancer	0.000243	0.00257	CcSEcCtD
Clobetasol propionate—Erythema—Dactinomycin—skin cancer	0.000239	0.00253	CcSEcCtD
Clobetasol propionate—Pain in extremity—Docetaxel—skin cancer	0.000239	0.00252	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Fluorouracil—skin cancer	0.000228	0.00241	CcSEcCtD
Clobetasol propionate—Alopecia—Temozolomide—skin cancer	0.000219	0.00232	CcSEcCtD
Clobetasol propionate—Dry skin—Docetaxel—skin cancer	0.000219	0.00231	CcSEcCtD
Clobetasol propionate—Rash—Vemurafenib—skin cancer	0.000218	0.0023	CcSEcCtD
Clobetasol propionate—Dermatitis—Vemurafenib—skin cancer	0.000217	0.0023	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Imiquimod—skin cancer	0.000217	0.00229	CcSEcCtD
Clobetasol propionate—Headache—Vemurafenib—skin cancer	0.000216	0.00229	CcSEcCtD
Clobetasol propionate—Erythema—Temozolomide—skin cancer	0.000216	0.00229	CcSEcCtD
Clobetasol propionate—Pruritus—Imiquimod—skin cancer	0.000208	0.0022	CcSEcCtD
Clobetasol propionate—Infection—Bleomycin—skin cancer	0.000208	0.0022	CcSEcCtD
Clobetasol propionate—Alopecia—Fluorouracil—skin cancer	0.000202	0.00214	CcSEcCtD
Clobetasol propionate—Erythema—Fluorouracil—skin cancer	0.000199	0.00211	CcSEcCtD
Clobetasol propionate—Infection—Dactinomycin—skin cancer	0.000194	0.00205	CcSEcCtD
Clobetasol propionate—Paraesthesia—Bleomycin—skin cancer	0.000188	0.00199	CcSEcCtD
Clobetasol propionate—Rash—Imiquimod—skin cancer	0.000186	0.00196	CcSEcCtD
Clobetasol propionate—Dermatitis—Imiquimod—skin cancer	0.000185	0.00196	CcSEcCtD
Clobetasol propionate—Headache—Imiquimod—skin cancer	0.000184	0.00195	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000183	0.00193	CcSEcCtD
Clobetasol propionate—Pain—Bleomycin—skin cancer	0.000179	0.00189	CcSEcCtD
Clobetasol propionate—Infection—Temozolomide—skin cancer	0.000175	0.00185	CcSEcCtD
Clobetasol propionate—Skin disorder—Temozolomide—skin cancer	0.000171	0.00181	CcSEcCtD
Clobetasol propionate—Pain—Dactinomycin—skin cancer	0.000167	0.00176	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Docetaxel—skin cancer	0.000164	0.00174	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Docetaxel—skin cancer	0.000163	0.00172	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Docetaxel—skin cancer	0.000162	0.00172	CcSEcCtD
Clobetasol propionate—Infection—Fluorouracil—skin cancer	0.000161	0.00171	CcSEcCtD
Clobetasol propionate—Paraesthesia—Temozolomide—skin cancer	0.000158	0.00167	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Bleomycin—skin cancer	0.000154	0.00163	CcSEcCtD
Clobetasol propionate—Pain—Temozolomide—skin cancer	0.000151	0.0016	CcSEcCtD
Clobetasol propionate—Pruritus—Bleomycin—skin cancer	0.000148	0.00156	CcSEcCtD
Clobetasol propionate—Paraesthesia—Fluorouracil—skin cancer	0.000146	0.00154	CcSEcCtD
Clobetasol propionate—Alopecia—Docetaxel—skin cancer	0.000146	0.00154	CcSEcCtD
Clobetasol propionate—Erythema—Docetaxel—skin cancer	0.000144	0.00152	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Dactinomycin—skin cancer	0.000144	0.00152	CcSEcCtD
Clobetasol propionate—Pain—Fluorouracil—skin cancer	0.000139	0.00147	CcSEcCtD
Clobetasol propionate—Rash—Bleomycin—skin cancer	0.000132	0.00139	CcSEcCtD
Clobetasol propionate—Dermatitis—Bleomycin—skin cancer	0.000132	0.00139	CcSEcCtD
Clobetasol propionate—Triamcinolone—PTGS2—skin cancer	0.00013	0.0711	CrCbGaD
Clobetasol propionate—Hypersensitivity—Temozolomide—skin cancer	0.00013	0.00137	CcSEcCtD
Clobetasol propionate—Pruritus—Temozolomide—skin cancer	0.000125	0.00132	CcSEcCtD
Clobetasol propionate—Rash—Dactinomycin—skin cancer	0.000123	0.0013	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000122	0.00129	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Fluorouracil—skin cancer	0.00012	0.00127	CcSEcCtD
Clobetasol propionate—Infection—Docetaxel—skin cancer	0.000117	0.00123	CcSEcCtD
Clobetasol propionate—Pruritus—Fluorouracil—skin cancer	0.000115	0.00122	CcSEcCtD
Clobetasol propionate—Skin disorder—Docetaxel—skin cancer	0.000114	0.0012	CcSEcCtD
Clobetasol propionate—Rash—Temozolomide—skin cancer	0.000111	0.00118	CcSEcCtD
Clobetasol propionate—Dermatitis—Temozolomide—skin cancer	0.000111	0.00118	CcSEcCtD
Clobetasol propionate—Headache—Temozolomide—skin cancer	0.00011	0.00117	CcSEcCtD
Clobetasol propionate—Betamethasone—PTGS2—skin cancer	0.000107	0.0582	CrCbGaD
Clobetasol propionate—Paraesthesia—Docetaxel—skin cancer	0.000105	0.00111	CcSEcCtD
Clobetasol propionate—Rash—Fluorouracil—skin cancer	0.000102	0.00108	CcSEcCtD
Clobetasol propionate—Dermatitis—Fluorouracil—skin cancer	0.000102	0.00108	CcSEcCtD
Clobetasol propionate—Headache—Fluorouracil—skin cancer	0.000102	0.00108	CcSEcCtD
Clobetasol propionate—Pain—Docetaxel—skin cancer	0.0001	0.00106	CcSEcCtD
Clobetasol propionate—CYP1A1—skin epidermis—skin cancer	9.72e-05	0.137	CbGeAlD
Clobetasol propionate—Hypersensitivity—Docetaxel—skin cancer	8.64e-05	0.000914	CcSEcCtD
Clobetasol propionate—Pruritus—Docetaxel—skin cancer	8.3e-05	0.000878	CcSEcCtD
Clobetasol propionate—NR3C1—nerve—skin cancer	8.04e-05	0.114	CbGeAlD
Clobetasol propionate—Rash—Docetaxel—skin cancer	7.4e-05	0.000782	CcSEcCtD
Clobetasol propionate—Dermatitis—Docetaxel—skin cancer	7.39e-05	0.000781	CcSEcCtD
Clobetasol propionate—Headache—Docetaxel—skin cancer	7.35e-05	0.000777	CcSEcCtD
Clobetasol propionate—Dexamethasone—PTGS2—skin cancer	6.2e-05	0.0339	CrCbGaD
Clobetasol propionate—CYP1A2—nipple—skin cancer	4.77e-05	0.0674	CbGeAlD
Clobetasol propionate—CYP1A1—nipple—skin cancer	4.7e-05	0.0665	CbGeAlD
Clobetasol propionate—NR3C1—nipple—skin cancer	4.56e-05	0.0645	CbGeAlD
Clobetasol propionate—NR3C1—neck—skin cancer	4.51e-05	0.0639	CbGeAlD
Clobetasol propionate—NR3C1—connective tissue—skin cancer	3.24e-05	0.0458	CbGeAlD
Clobetasol propionate—CYP1A1—epithelium—skin cancer	3.17e-05	0.0448	CbGeAlD
Clobetasol propionate—NR3C1—epithelium—skin cancer	3.07e-05	0.0435	CbGeAlD
Clobetasol propionate—CYP1A1—skin of body—skin cancer	3.01e-05	0.0426	CbGeAlD
Clobetasol propionate—NR3C1—skin of body—skin cancer	2.92e-05	0.0413	CbGeAlD
Clobetasol propionate—CYP1A1—mammalian vulva—skin cancer	2.75e-05	0.0388	CbGeAlD
Clobetasol propionate—NR3C1—mammalian vulva—skin cancer	2.66e-05	0.0377	CbGeAlD
Clobetasol propionate—NR3C1—lymphoid tissue—skin cancer	2.37e-05	0.0335	CbGeAlD
Clobetasol propionate—CYP1A1—female reproductive system—skin cancer	2.35e-05	0.0333	CbGeAlD
Clobetasol propionate—NR3C1—female reproductive system—skin cancer	2.28e-05	0.0323	CbGeAlD
Clobetasol propionate—CYP1A1—head—skin cancer	1.96e-05	0.0278	CbGeAlD
Clobetasol propionate—NR3C1—head—skin cancer	1.91e-05	0.027	CbGeAlD
Clobetasol propionate—CYP1A1—lymph node—skin cancer	1.38e-05	0.0195	CbGeAlD
Clobetasol propionate—NR3C1—lymph node—skin cancer	1.33e-05	0.0189	CbGeAlD
